MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Twist Bioscience Corp

Closed

SectorHealthcare

38 0.61

Overview

Share price change

24h

Current

Min

37.06

Max

38.2

Key metrics

By Trading Economics

Income

-7.7M

-39M

Sales

4.1M

93M

EPS

-0.659

Profit margin

-42.383

Employees

923

EBITDA

-21M

-46M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+25.88% upside

Dividends

By Dow Jones

Next Earnings

1 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-136M

2.2B

Previous open

37.39

Previous close

38

News Sentiment

By Acuity

50%

50%

157 / 375 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Twist Bioscience Corp Chart

Past performance is not a reliable indicator of future results.

Related News

3 Jul 2025, 23:45 UTC

Acquisitions, Mergers, Takeovers

Orix Corp. USA to Buy Majority Stake in Hilco Global >8591.TO

3 Jul 2025, 23:42 UTC

Market Talk

Gold Edges Higher Amid U.S. Fiscal-Deficit Concerns -- Market Talk

3 Jul 2025, 23:41 UTC

Market Talk

Nikkei May Rise After Solid U.S. Jobs Data -- Market Talk

3 Jul 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 Jul 2025, 23:15 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Beach Energy Could Smooth Path to Santos Takeover Approval -- Market Talk

3 Jul 2025, 22:59 UTC

Market Talk

Uranium Market About to Enter Lull -- Market Talk

3 Jul 2025, 22:58 UTC

Market Talk

Value Emerging in Diversified Miners Despite Headwinds -- Market Talk

3 Jul 2025, 22:47 UTC

Market Talk

Australian Household Spending Numbers Key Ahead of RBA Meeting -- Market Talk

3 Jul 2025, 22:21 UTC

Earnings

This Summer's Big TV Hit Brings Back Soap Opera Memories -- Barrons.com

3 Jul 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

3 Jul 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 Jul 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

3 Jul 2025, 20:41 UTC

Market Talk

KKR Seen As Benefiting From Stabilizing Markets -- Market Talk

3 Jul 2025, 20:41 UTC

Market Talk

Global Equities Roundup: Market Talk

3 Jul 2025, 19:28 UTC

Market Talk

Oil Gives Back Some Gains With OPEC+ in View -- Market Talk

3 Jul 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Retreats Ahead of Long Weekend -- Market Talk

3 Jul 2025, 18:34 UTC

Market Talk

Gold Has Winning Week, But Down Day -- Market Talk

3 Jul 2025, 18:18 UTC

Market Talk

Anticipation for Trump Address Gives Grain Traders Optimism -- Market Talk

3 Jul 2025, 18:06 UTC

Market Talk

Global Equities Roundup: Market Talk

3 Jul 2025, 18:06 UTC

Market Talk

Brazilian Stocks, Bonds Expected to Benefit From Benign Macro Trends -- Market Talk

3 Jul 2025, 17:27 UTC

Market Talk

U.S. Oil Rig Count Continues to Slide -- Market Talk

3 Jul 2025, 16:55 UTC

Earnings

Travel Stocks Could Offer Investors a Glorious -2-

3 Jul 2025, 16:55 UTC

Earnings

Travel Stocks Could Offer Investors a Glorious Trip, This Analyst Says -- Barrons.com

3 Jul 2025, 16:20 UTC

Market Talk

Correction to Health Care Roundup: Market Talk

3 Jul 2025, 16:15 UTC

Market Talk

Oil Futures Lose Ground in Choppy Pre-Holiday Trade -- Market Talk

3 Jul 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

3 Jul 2025, 16:05 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 Jul 2025, 16:05 UTC

Market Talk

Gold Futures Fall Following Jobs Report -- Market Talk

3 Jul 2025, 15:47 UTC

Earnings

Honeywell Stock Is on a Roll. It Looks Ready to Break Out. -- Barrons.com

3 Jul 2025, 15:36 UTC

Earnings
Acquisitions, Mergers, Takeovers

Why It's Time to Buy This Rocks and Cement Spinoff Stock You've Probably Never Heard Of -- Barrons.com

Peer Comparison

Price change

Twist Bioscience Corp Forecast

Price Target

By TipRanks

25.88% upside

12 Months Forecast

Average 47.43 USD  25.88%

High 62 USD

Low 33 USD

Based on 8 Wall Street analysts offering 12 month price targets forTwist Bioscience Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

6

Buy

1

Hold

1

Sell

Technical Score

By Trading Central

31.56 / 38.6884Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

157 / 375 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.